Singapore Paincare Holdings Limited Issues Monthly Update on Subsidiary’s Creditors’ Voluntary Winding-Up

Key Highlights

• Ongoing Creditors’ Voluntary Winding-Up: Singapore Paincare Holdings Limited (“the Company”) has provided a monthly update regarding the creditors’ voluntary winding-up of its 51.0%-owned subsidiary, Dermatology & Laser Specialist Clinic Pte. Ltd. (“DLS”).
• No Material Developments: Since the last update on 26 February 2026, there have been no significant changes or new developments concerning the winding-up process of DLS.
• Regulatory Compliance: The Company is giving these monthly updates in compliance with Catalist Rule 704(22) to ensure shareholders are kept informed of any material developments.

Details for Investors

The Board of Directors of Singapore Paincare Holdings Limited wishes to remind shareholders that the process of winding-up DLS, a subsidiary in which the Group holds a 51% stake, is ongoing. The Company previously made announcements on 3 February 2026 and 26 February 2026 regarding the initiation and progress of this voluntary creditors’ winding-up.

As of the latest update (26 March 2026), the Company confirms that there have been no new developments or material events since the last monthly disclosure. This means that the status of DLS’s winding-up remains unchanged, with no new impacts, recoveries, or liabilities reported.

Shareholder Advisory

• Potential for Share Price Impact: The process of winding up a subsidiary may be considered price-sensitive information, especially as it could affect the Group’s overall financial position, contingent liabilities, and business focus. However, the Company has explicitly stated that as of this update, there are no changes to the previous situation which would warrant a revaluation of the Company’s shares.
• Action for Shareholders: Shareholders are strongly advised not to take any action in respect of their securities that may be prejudicial to their interests based on this announcement. They should exercise caution when dealing in the Company’s securities.
• Professional Advice: In case of any doubt or uncertainty regarding the implications of the winding-up process, shareholders are encouraged to consult their stockbrokers, bank managers, solicitors, accountants, or other professional advisers.
• Ongoing Updates: The Company commits to continuing its practice of monthly updates and will make further announcements if there are any material developments in the winding-up process.

Other Regulatory Notes

The Company’s announcement has been reviewed by its sponsor, Novus Corporate Finance Pte. Ltd., but has not been examined or approved by the Singapore Exchange Securities Trading Limited (SGX-ST). The SGX-ST assumes no responsibility for the contents of this announcement.

Contact details for the Company’s sponsor are provided for further queries: Mr Pong Chen Yih, Chief Operating Officer, Novus Corporate Finance Pte. Ltd., 7 Temasek Boulevard, #04-02 Suntec Tower 1, Singapore 038987, telephone (65) 6950 2188.

Conclusion

Summary for Investors: As of this update, there are no new developments regarding the creditors’ voluntary winding-up of Dermatology & Laser Specialist Clinic Pte. Ltd. Shareholders should remain vigilant and await further updates from the Company, given the potential for future announcements to impact share value depending on how the winding-up process progresses.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Shareholders and investors should seek independent professional advice before making any investment decisions. The Company and its sponsor accept no liability for any loss or damage arising from reliance on the information provided above.

View Sing Paincare Historical chart here